Publications & Works

Published journal articles indexed by SCI, SSCI, and AHCI

Articles Published in Other Journals

Türkiye Klinikleri

Türkiye Klinikleri , vol.1, no.1, pp.53-58, 2019 (Peer-Reviewed Journal)

Akut Graft Versus Host Hastalığı

Turkiye Klinikleri , vol.10, no.4, pp.221-227, 2017 (Peer-Reviewed Journal)

Refereed Congress / Symposium Publications in Proceedings

HLA heterozigotluğu bağırsak mikrobiyotasını etkiler mi?

18. TIBBİ BİYOLOJİ VE GENETİK KONGRESİ, Ankara, Turkey, 26 - 29 October 2023, pp.15-16

CARDIAC AL AMYLOIDOSIS EXPERIENCED IN THE LAST DECADE FROM A SINGLE CENTER

IMS 20th Annual Meeting and Exhibition, Athens, Greece, 27 - 30 September 2023, pp.425

THE GUT MICROBIOTA CHANGES DURİNG MULTIPLE MYELOMA TREATMENT

IMS 20TH Annual Meeting and Exhibition , Athens, Greece, 27 - 30 September 2023, pp.395

TCL-223 Clonal CD4+ Cytotoxic T Lymphocytosis Concomitant With POEMS Syndrome: A Co-Existence of Key Findings for Relevance in the Pathogenesis

Proceedings of the Society of Hematologic Oncology 2023 Annual Meeting, Texas, United States Of America, 06 September 2023, vol.23, pp.467-468

IMPACT OF EPITOPE MATCH ON STEM CELL TRANSPLANTATION

SOHO23 Türkiye Tenth Annual Meeting, İstanbul, Turkey, 5 - 07 May 2023, pp.33

Edinsel saf eritroit dizi aplazi tedavisi seyrinde Hodgkin Dışı Lenfoma: De novo? İmmunsupresif tedavi ilişkili?

İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2023, Sapanca, Turkey, 09 March 2023, pp.29-30

Kan ürünleri transfüzyonları sorunlar ve çözümler

İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2023, Sapanca, Turkey, 09 March 2023, pp.9-11

A rare presentation of systemic AL amyloidosis; Pulmonary AL amyloidosis

XIII Eurasian Hematology Oncology Congress EHOC 2022, İstanbul, Turkey, 05 October 2022, vol.44, pp.19

An unusual ocular lymphoma, primary intravitreal lymphoma diagnosed incidentally

XIII Eurasian Hematology Oncology Congress EHOC 2022, İstanbul, Turkey, 05 October 2022, vol.44, pp.30-31

Epitop Uyumsuzluklarının Hematopoetik Kök Hücre Nakli Üzerine Etkisi

8. Ulusal Transplantasyon İmmunolojisi ve Genetiği Kongresi, Antalya, Turkey, 14 - 17 April 2022, pp.88-89

Epitop Uyumsuzluklarının Hematopoetik Kök Hücre Nakli Üzerine Etkisi

8. ULUSAL TRANSPLANTASYON İMMÜNOLOJİSİ VE GENETİĞİ KONGRESİ, Antalya, Turkey, 14 - 17 April 2022, pp.88

İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2022, Sakarya, Turkey, 24 - 27 March 2022, pp.37-38

Relationship between HLA and COVID-19 in unrelated bone marrow donors

Hacettepe Acta Medica- XVII. Congress of Medical Biology and Genetics, 28 - 31 October 2021, vol.52, pp.407-408 Creative Commons License

ASPARAGINASE INDUCED SINUS VEIN THROMBOSIS IN AN ADULT YOUNG ALL PATIENT

XIIth Eurasian Hematology-Oncology Congress, İSTANBUL (Hibrit Kongre), Turkey, 10 November 2021, vol.43, pp.77

WHAT HAVE WE EXPERIENCED WITH COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISORDERS?

XIIth Eurasian Hematology-Oncology Congress, İSTANBUL (Hibrit Kongre), Turkey, 10 November 2021, vol.43, pp.96

A CASE OF MULTI REGIONAL PRIMARY MUSCLE LYMPHOMA

XIIth Eurasian Hematology-Oncology Congress, İstanbul, Turkey, 10 - 13 November 2021, pp.41

Potential Predictors of Outcome for Anakinra Treatment inCOVID-19 Patients with Macrophage Activation Syndrome

American College of Rheumatology, Arizona, United States Of America, 5 - 09 November 2021, vol.10, no.73, pp.1-5 Creative Commons License

Preliminary Criteria for Macrophage Activation SyndromeAssociated with Coronavirus Disease-19

American College of Rheumatology 2021, Arizona, United States Of America, 5 - 09 November 2021, vol.10, no.73, pp.1-4 Creative Commons License Sustainable Development

Microbiota Analysis After Allogeneic Stem Cell Transplantation in Blood Diseases

Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Kongresi, İstanbul, Turkey, 26 - 30 May 2021, pp.1-3

CASTLEMAN HASTALIĞI’NIN NADIR BIR FORMU: TAFRO SENDROMU

Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme, İstanbul, Turkey, 11 March 2021

COVID-19 hastalarında Antitrombin-III seviyelerinin prognostik önemi

20. Ulusal Yoğun Bakım E- Kongresi (uluslararası katılımı) , İstanbul, Turkey, 10 - 15 November 2020, pp.1 Sustainable Development

LANGERHANS HÜCRELİ HİSTİYOSİTOZ: TEK MERKEZ DENEYİMİ

45. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 01 November 2019, pp.155-156

Serological weak d phenotypes and RHD genotype frequency among Turkish blood donors

10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85 identifier

Late renal aspergilloma after autologous stem cell transplantion mimicking secondary malignancy

10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85 identifier

Clinical relevance of minor histocompatibility antigens

10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85 identifier

Comparison of outcomes of total body irradiation (TBI) vs non-TBI conditioning regimens in acute lymphoblastic leukemia for allogeneic transplantation

45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 24 - 27 March 2019, vol.54, pp.217-218 identifier

Multiple red blood cell alloantibodies after blood transfusions in a nonhematologic patient

IXth International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, no.1, pp.68

Multiple red blood cell alloantibodies after blood transfusions in a nonhematologic patient

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, no.1, pp.68

Multiple red blood cell alloantibodies after blood transfusions in a nonhematologic patient

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73 identifier

Investigation of B-lymphocyte F-actin cell skeleton in multiple myeloma patients

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73 identifier

Chimerism by lineage-specific analysis in the course of clinical outcome

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73 identifier

qRT-PCR and STR-PCR chimerism method using after allogeneic hematopoietic stem cell transplantation

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73 identifier

Infectious epidemiology in Multiple Myeloma patients after Autologous Stem Cell Transplantation: A single-center analysis from Turkey

44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.566-567 identifier

Secondary primary malignancies after autologuous hematopoietic stem cell transplantation: Single center experience

44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.368-369 identifier

Hematopoetik kök hücre nakli (HKHN) yapılan hastalardaki infeksiyonlardan sorumlu bakterilerin değerlendirilmesi

KLİMİK 2015 XVII. TÜRK KLİNİK MİKROBİYOLOJİ VE İNFEKSİYON HASTALIKLARI KONGRESİ, Antalya, Turkey, 25 - 29 March 2015, pp.297-298

The impact of donor specific anti-HLA antibodies on the outcome of allogeneic stem cell transplantation

41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Turkey, 22 - 25 March 2015, vol.50 identifier

THE IMPACT OF DONOR SPECIFIC ANTI-HLA AND ANTI-GSTT1 ANTIBODIES ON THE OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION

28th EFI European Immunogenetics and Histocompatibility Conference, Stockholm, Sweden, 25 - 28 June 2014, vol.84, pp.56-57 identifier

INVESTIGATION OF LINEAGE-SPECIFIC AND PERIPHERAL BLOOD CHIMERISM ANALYSIS IN POST-STEM CELL TRANSPLANT PATIENTS

28th EFI European Immunogenetics and Histocompatibility Conference, Stockholm, Sweden, 25 - 28 June 2014, vol.84, pp.55-56 identifier

Allogegneik kök hücre nakli sonrası anti-HLA ve anti-GSTT1 antikorlarının nakil başarısı üzerine etkisi.

8. Ulusal Kemik İliği Transplantasyonu ve Kök hücre tedavileri kongresi, Antalya, Turkey, 6 - 08 March 2014, pp.153-154

CHIMERISM STATUS AND ITS EFFECT ON CLINICAL OUTCOME AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TANSPLANTATION

40th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Milan, Italy, 30 March - 02 April 2014, vol.49 identifier

Lenalidomide in relapsed/refractory mantle cell lymphoma post-bortezomib: Subgroup analysis of the MCL-001 study

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31 identifier

Combined analysis of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31 identifier

TYPING OF RELATIVES OF PATIENTS BEING CONSIDERED FOR ALLOGENEIC STEM CELL TRANSPLANTATION

Joint 16th International HLA and Immunogenetics Workshop/26th European Federation for Immunogenetics Conference/23rd British-Society-of-Histocompatibility-and-Immunogenetics Conference, Liverpool, United Kingdom, 31 May - 03 June 2012, vol.79, pp.441-442 identifier

How did the sibling donor's manage their lives?: a 13-year follow-up survey on the impact of giving stem cell

38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), Geneva, Switzerland, 1 - 04 April 2012, vol.47 identifier

Bacillus cereus Catheter Related Bloodstream Infection in a Patient with Acute Lymphoblastic Leukemia

8th International Symposium on Antimicrobial Agents and Resistance (ISAAR), Seul, South Korea, 6 - 08 April 2011, pp.292

Miyeloid Lösemilerde Kromozomal Anomaliler.

XI. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Turkey, 28 - 31 October 2009, pp.57-58

İstanbul Tıp Fakültesi Kemik İliği Bankası (İTF KİBANK).

35. Ulusal Hematoloji Kongresi, Antalya, Turkey, 7 - 10 October 2009, pp.1-2

Does the frequency of chromosomal aberrations change with age and gender in acute myeloid leukemia?

21st European Immunogenetics and Histocompatibility Conference, Barcelona, Spain, 5 - 08 May 2007, vol.69, pp.461 identifier

Variant Philadelphia translocations in patients with Chronic Myeloid Leukemia

6th European Cytogenetics Conference, İstanbul, Turkey, 7 - 10 July 2007, pp.202 identifier

Does previous interferon use have negative effect on imatinib response in chronic myeloid leukemia (CML)? A single center study.

48th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 9 - 12 December 2006, vol.108 identifier

HLA-A*11, -B*15, -DRB1*08 and homozygosity for HLA-B-DRB1 are associated with risk in multiple myeloma

20th European Immunogenetics and Histocompatibility Conference, Oslo, Norway, 8 - 11 June 2006, vol.67, pp.533-534 identifier

The incidence of Ph chromosome and Trisomy 8 in chronic myeloid patients

20th European Immunogenetics and Histocompatibility Conference, Oslo, Norway, 8 - 11 June 2006, vol.67, pp.548-549 identifier

Determination of cytokine gene polymorphisms in patients with multiple myeloma

20th European Immunogenetics and Histocompatibility Conference, Oslo, Norway, 8 - 11 June 2006, vol.67, pp.542-543 identifier

Chimerism monitoring by short tandem repeat (STR) analysis in HSCT

19th European Immunogenetics and Histocompatibility Conference, İstanbul, Turkey, 23 - 26 April 2005, vol.6 identifier

The association between HLA markers and oral mucositis in allogeneic hematopoietic cell transplantation

19th European Immunogenetics and Histocompatibility Conference, İstanbul, Turkey, 23 - 26 April 2005, vol.6 identifier

The relationship between minor histocompatibility antigens and graft-versus-host disease after allogeneic haematopoietic stem cell transplantation

31st Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/21st Meeting of the EBMT-Nurses-Group/4th Meeting of the EBMT-Data-Management-Group, Prague, Czech Republic, 20 - 23 March 2005, vol.35 identifier

The negative impact of stem cell transplantation on psychological status; a single-centre experience

30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group, Barcelona, Spain, 28 - 31 March 2004, vol.33 identifier

Incidence and outcome of renal dysfunction early in the course of haematopoietic cell transplantation

30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group, Barcelona, Spain, 28 - 31 March 2004, vol.33 identifier

Quality of life assessment of haematopoietic stem cell transplantation patients in Istanbul: a pilot study

30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group, Barcelona, Spain, 28 - 31 March 2004, vol.33 identifier

Oral lesions and hygiene in stem cell recipients with graft versus host disease.

45th Annual Meeting of the American-Society-of-Hematology, SAN DIEGO, CALIFORNIA, 6 - 09 December 2003, vol.102 identifier

The association of HLA class I antigens and class II alleles with multiple myeloma in Turkey.

45th Annual Meeting of the American-Society-of-Hematology, SAN DIEGO, CALIFORNIA, 6 - 09 December 2003, vol.102 identifier

Change in serum procalcitonin has diagnostic and prognostic value for most early complications in stem cell transplantation

29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Turkey, 23 - 26 March 2003, vol.31 identifier

Unrelated hematopoietic stem cell transplantation: Istanbul University/Istanbul medical faculty bone marrow registry (Kibank): a pioneering role in turkey

29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Turkey, 23 - 26 March 2003, vol.31 identifier

HLA full match donors

29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Turkey, 23 - 26 March 2003, vol.31 identifier

What people having hematologic malignancies and people of good health think about infertility

29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Turkey, 23 - 26 March 2003, vol.31 Sustainable Development identifier

Interleukin-6 gene polymorphisms associate with acute graft-versus-host disease in HLA-matched allogeneic hematopoietic stem cell transplantation

29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Turkey, 23 - 26 March 2003, vol.31 identifier

The effect of stem cell transplantation on social and economic status in a developing country on family basis

29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Turkey, 23 - 26 March 2003, vol.31 identifier

Extracorporeal photoimmunotherapy for treatment of steroid refractory extensive chronic graft versus host disease: Turkish experience

29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Turkey, 23 - 26 March 2003, vol.31 identifier

Effect of methylenetetrahydrofolate reductase gene polymorphism on methotrexate toxicity after bone marrow transplantation

29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Turkey, 23 - 26 March 2003, vol.31 identifier

Procalcitonin in stem cell transplantation: It has highly diagnostic and prognostic value for most early complications.

44th Annual Meeting of the American-Society-of-Hematology, PHILADELPHIA, PENNSYLVANIA, 6 - 10 December 2002, vol.100 identifier

Books & Book Chapters

Kalp Transplantasyonunda Güncel Hematolojik İzlem ve Yaklaşımlar

in: Kalp Transplantasyonunda Güncel Yaklaşımlar, Nilgün Bozbuğa, Editor, Türkiye Klinikleri, Ankara, pp.142-149, 2023

Herediter Plazminojen Eksikliği İlişkili Lignöz Konjonktivit

in: OLGULARLA KANAYAN ÇOCUK, AYŞEGÜL ÜNÜVAR, CANAN ALBAYRAK, DİLEK GÜRLEK GÖKÇEBAY, ELİF GÜLER KAZANCI, KAHRAMAN ÖNCEL, Editor, GALENOS, İstanbul, pp.35-40, 2023

HEMATOLOJİK HASTALIKLARDA ORAL DİAGNOZ

in: Multidisipliner Prensiplerle Oral Diagnoz, İlknur Özcan, Editor, İstanbul Tıp Kitapevi, İstanbul, pp.150-153, 2022

Kanama ve Koagülasyon Bozuklukları

in: TRAVMA, Cemalettin ERTEKİN, Editor, EMA Tıp Kitabevi Yayıncılık Tic. Ltd. Şti., İstanbul, pp.1326-1332, 2022

Hodgkin Dışı Lenfomalarda Hedefe Yönelik Tedaviler

in: Hematolojik Kanserlerde Hedefe Yönelik Tedaviler, İlhami Kiki, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.35-44, 2021 Sustainable Development

Anemi

in: Geriatri Yaşlı Sağlığı ve Hastalıkları, Prof. Dr. Zekeriya Ülger Prof. Dr. Ü. Deniz Erdinçler Prof. Dr. Mehmet Akif Karan, Editor, HİPOKRAT, Ankara, pp.1-14, 2021 Creative Commons License

Endotel Hastalıkları ve Hematolojik Komplikasyonlar

in: İmmünohematolojide Güncel Başlıklar, Gülsan Türköz Sucak, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.25-30, 2021

Hodgkin Dışı Lenfomalarda Hedefe Yönelik Tedaviler

in: HEMATOLOJİK KANSERLERDE HEDEFE YÖNELİK TEDAVİLER, KİKİ İLHAMİ, Editor, Türkiye Klinikleri Hematoloji, Ankara, pp.35-44, 2021